207 related articles for article (PubMed ID: 31764852)
21. Adenosarcoma of the uterine body in a 19-year-old woman--three year survival: case report.
Fait T; Zivny J; Freitag P; Kuzel D
Eur J Gynaecol Oncol; 2001; 22(1):61-3. PubMed ID: 11321498
[TBL] [Abstract][Full Text] [Related]
22. Uterine adenosarcoma with sarcomatous overgrowth: a case report with cytology of overgrown poorly differentiated sarcoma and immunohistochemical identification of epithelial microinvasion.
Nagai Y; Kishimoto T; Kato K; Ozaki D; Kondo F; Kobayashi A; Shimizu H; Ishikura H
Int J Gynecol Cancer; 2002; 12(5):501-5. PubMed ID: 12366670
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for uterine adenosarcoma: a review.
Nathenson MJ; Conley AP
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1093-1100. PubMed ID: 30169984
[TBL] [Abstract][Full Text] [Related]
24. Low grade Mullerian adenosarcoma of pouch of Douglas recurring as bilateral ovarian high grade Mullerian adenosarcoma with rhabdomyosarcomatous overgrowth after 11 years.
Kumar S; Raza M; Tariq MU
J Pak Med Assoc; 2018 Aug; 68(8):1263-1266. PubMed ID: 30108400
[TBL] [Abstract][Full Text] [Related]
25. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
26. Two unusual presentations of müllerian adenosarcoma: case reports, literature review, and treatment considerations.
Gollard R; Kosty M; Bordin G; Wax A; Lacey C
Gynecol Oncol; 1995 Dec; 59(3):412-22. PubMed ID: 8522267
[TBL] [Abstract][Full Text] [Related]
27. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract][Full Text] [Related]
28. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
30. Müllerian adenosarcoma of the uterus: report of a case with imprint cytology.
Takeshima N; Tabata T; Nishida H; Arai Y; Tsuzuku M; Hirai Y; Yamauchi K; Hasumi K
Acta Cytol; 2001; 45(4):613-6. PubMed ID: 11480728
[TBL] [Abstract][Full Text] [Related]
31. Post-radiation Mullerian adenosarcoma with sarcomatous overgrowth: rare presentation of an uncommon malignancy.
Mubeen A; Shahid M; Makary R
Pathologica; 2020 Dec; 112(4):219-223. PubMed ID: 33393526
[TBL] [Abstract][Full Text] [Related]
32. Clinical management of uterine cervical mullerian adenosarcoma: A clinicopathological study of six cases and review of the literature.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):479-482. PubMed ID: 30122564
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of malignant mesenchymal uterine tumors by hysteroscopic excisional biopsy.
Shveiky D; Revel A; Rojansky N; Benshushan A; Shushan A
J Minim Invasive Gynecol; 2005; 12(1):29-33. PubMed ID: 15904594
[TBL] [Abstract][Full Text] [Related]
34. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.
Carroll A; Ramirez PT; Westin SN; Soliman PT; Munsell MF; Nick AM; Schmeler KM; Klopp AH; Fleming ND
Gynecol Oncol; 2014 Dec; 135(3):455-61. PubMed ID: 25449308
[TBL] [Abstract][Full Text] [Related]
35. Uterine Adenosarcoma with Sarcomatous Overgrowth and Rhabdoid Features: A Rare Case.
Rashid S; Akhtar M
Saudi J Med Med Sci; 2022; 10(1):72-76. PubMed ID: 35283707
[TBL] [Abstract][Full Text] [Related]
36. Müllerian adenosarcoma: a review of cases and literature.
Huang PS; Chang WC; Huang SC
Eur J Gynaecol Oncol; 2014; 35(6):617-20. PubMed ID: 25556263
[TBL] [Abstract][Full Text] [Related]
37. Uterine Adenosarcoma Originating in Adenomyosis: Report of an Extremely Rare Phenomenon and Review of Published Literature.
Talia KL; Naaman Y; McCluggage WG
Int J Gynecol Pathol; 2021 Jul; 40(4):342-348. PubMed ID: 32947330
[TBL] [Abstract][Full Text] [Related]
38. Fertility-sparing treatment for cervical mullerian adenosarcoma: A case report and literature review.
Xiao B; Li R; Zhao X; Mao X; He S; Xu D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 47(11):1622-1628. PubMed ID: 36481642
[TBL] [Abstract][Full Text] [Related]
39. A rare case of the new entity of müllerian anomalies mimicking the noncommunicating rudimentary cavity with hemi-uterus: accessory cavitated uterine mass.
Tokgoz VY; Tekin AB
Fertil Steril; 2022 Mar; 117(3):646-648. PubMed ID: 35058046
[TBL] [Abstract][Full Text] [Related]
40. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
Eur J Cancer; 2020 Nov; 139():149-168. PubMed ID: 32992154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
